版本:
中国

BRIEF-Akebia announces publication of Phase 2b data for vadadustat

Sept 19 Akebia Therapeutics Inc :

* Announces publication of Phase 2b data for vadadustat in non-dialysis patients with anemia related to chronic kidney disease

* Vadadustat was generally well tolerated in Phase 2b trial and overall adverse events were balanced between treatment and placebo groups. Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐